JRCT ID: jRCTs031180043
Registered date:27/11/2018
EMPYREAN Study
Basic Information
| Recruitment status | Complete |
|---|---|
| Health condition(s) or Problem(s) studied | type 2 diabetes mellitus |
| Date of first enrollment | 22/01/2018 |
| Target sample size | 134 |
| Countries of recruitment | |
| Study type | Interventional |
| Intervention(s) | Empagliflozin 10mg/day or Sitagliptin 50mg/day |
Outcome(s)
| Primary Outcome | Change in LF/HF at 24 weeks after the treatment |
|---|---|
| Secondary Outcome | Body Height, Body Weight, BMI, HbA1c |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | < 75age old |
| Gender | Both |
| Include criteria | Type 2 DM (HbA1c 6.5-10%) . HbA1c 7.0-10% for patients who are taking sulfonylurea/glinides. |
| Exclude criteria | Treated with Insulin, GLP-1 analogue, SGLT2/DPP4 inhibitors |
Related Information
| Primary Sponsor | Kuwahara Kouichiro |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Nippon Boehringer Ingelheim Co., Ltd |
| Secondary ID(s) | UMIN000029194 |
Contact
| Public contact | |
| Name | Hirohiko Motoki |
| Address | Asahi 3-1-1, Matsumoto, Nagano, JAPAN Nagano Japan 390-8621 |
| Telephone | +81-263-37-3486 |
| hmotoki@shinshu-u.ac.jp | |
| Affiliation | Department of Cardiovascular Medicine, Shinshu University School of Medicine |
| Scientific contact | |
| Name | Kouichiro Kuwahara |
| Address | Asahi 3-1-1, Matsumoto, Nagano, JAPAN Nagano Japan 390-8621 |
| Telephone | +81-263-37-3486 |
| kkuwah@shinshu-u.ac.jp | |
| Affiliation | Department of Cardiovascular Medicine, Shinshu University School of Medicine |